| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 01/06/2023 | Precipio, Inc. | PRPO | Grant | Stock Option (Right to Buy) | 30k | $0.62 | $18.6k | | 01/06/2023 |
| 01/11/2022 | Precipio, Inc. | PRPO | Grant | Stock Option (Right to Buy) | 40k | $1.54 | $61.6k | | 01/11/2022 |
| 10/08/2021 | PHOENIX BIOTECH ACQUISITION CORP. | | Other (acquisition) | Class A common stock | 10k | $0.00 | $0 | By Phoenix Biotech Sponsor, LLC | 10/08/2021 |
| 10/08/2021 | PHOENIX BIOTECH ACQUISITION CORP. | | Other (acquisition) | Class B Common Stock | 100k | $0.00 | $0 | By Phoenix Biotech Sponsor, LLC | 10/08/2021 |
| 10/08/2021 | PHOENIX BIOTECH ACQUISITION CORP. | | Other (acquisition) | Warrants | 5k | $11.50 | $57.5k | By Phoenix Biotech Sponsor, LLC | 10/08/2021 |
| 08/03/2021 | Precipio, Inc. | PRPO | Grant | Stock Option (Right to Buy) | 25k | $3.22 | $80.5k | | 08/03/2021 |
| 01/04/2021 | Precipio, Inc. | PRPO | Grant | Stock Option (Right to Buy) | 25k | $2.10 | $52.5k | | 01/04/2021 |
| 09/16/2020 | ReShape Lifesciences Inc. | OBLN | Grant | Stock Option (Right to Buy) | 27.2k | $0.77 | $21k | | 09/16/2020 |
| 09/16/2020 | ReShape Lifesciences Inc. | OBLN | Grant | Stock Option | 27.2k | $0.00 | $0 | | 09/16/2020 |
| 07/02/2020 | Precipio, Inc. | PRPO | Grant | Stock Option (Right to Buy) | 4k | $1.30 | $5.2k | | 07/02/2020 |
| 01/16/2020 | Precipio, Inc. | PRPO | Grant | Stock Option (Right to Buy) | 7.5k | $2.14 | $16k | | 01/16/2020 |
| 07/23/2019 | ReShape Lifesciences Inc. | OBLN | Grant | Common Stock (Restricted Stock Units) | 78.1k | $0.00 | $0 | | 07/23/2019 |
| 03/18/2019 | Precipio, Inc. | PRPO | Grant | Stock Option (Right to Buy) | 75k | $0.15 | $11.2k | | 03/18/2019 |
| 06/13/2018 | ReShape Lifesciences Inc. | OBLN | Grant | Stock Option (Right to Buy) | 81.8k | $2.36 | $193k | | 06/13/2018 |
| 02/16/2018 | Precipio, Inc. | PRPO | Grant | Stock Option (Right to Buy) | 77.6k | $0.71 | $55.1k | | 02/16/2018 |
| 02/16/2018 | Precipio, Inc. | PRPO | Grant | Stock Option (Right to Buy) | 31k | $0.71 | $22k | | 02/16/2018 |
| 11/09/2016 | ReShape Lifesciences Inc. | OBLN | Grant | Stock Option (right to buy) | 46.5k | $8.74 | $406.4k | | 11/09/2016 |